Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News United Therapeutics Corp UTHR

Healthcare Biotechnology
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended... see more

Recent & Breaking News (NDAQ:UTHR)

United Therapeutics Corporation To Announce Third Quarter 2015 Financial Results Before Market Open On Tuesday, October 27, 2015

PR Newswire October 21, 2015

United Therapeutics Announces Additional $500 Million Share Repurchase Program

PR Newswire October 15, 2015

United Therapeutics Announces Settlement of Patent Litigation with Sandoz Inc.

PR Newswire September 30, 2015

Synthetic Genomics Inc. Expands Collaborative Research and Development Agreement with Lung Biotechnology PBC, a Subsidiary of United Therapeutics Corporation, to Develop Organs for Transplantation

PR Newswire September 22, 2015

United Therapeutics Corporation Agrees to Sell Priority Review Voucher to AbbVie for $350 Million

PR Newswire August 19, 2015

European Commission Grants Marketing Authorisation for Unituxin(TM) (dinutuximab) for the Treatment of Paediatric High-Risk Neuroblastoma

PR Newswire August 17, 2015

United Therapeutics Corporation To Present At The 2015 Wedbush PacGrow Healthcare Conference

PR Newswire August 6, 2015

United Therapeutics Corporation Reports Second Quarter 2015 Financial Results

PR Newswire July 28, 2015

United Therapeutics Corporation To Announce Second Quarter 2015 Financial Results Before Market Open On Tuesday, July 28, 2015

PR Newswire July 22, 2015

Dean Judy D. Olian Joins the United Therapeutics Corporation Board of Directors

PR Newswire June 29, 2015

United Therapeutics Corporation Receives Paragraph IV Notice Letter for Tyvaso

PR Newswire June 15, 2015

United Therapeutics Corporation To Present At The Jefferies 2015 Global Healthcare Conference

PR Newswire May 29, 2015

United Therapeutics Corporation To Present At The Deutsche Bank 40th Annual Health Care Conference

PR Newswire May 1, 2015

United Therapeutics Corporation Reports First Quarter 2015 Financial Results

PR Newswire April 28, 2015

United Therapeutics Corporation To Announce First Quarter 2015 Financial Results Before Market Open On Tuesday, April 28, 2015

PR Newswire April 21, 2015

United Therapeutics Receives a Rare Pediatric Disease Priority Review Voucher following the Approval of Unituxin(TM) for Pediatric High-Risk Neuroblastoma

PR Newswire March 10, 2015

FDA Approves Unituxin(TM) (dinutuximab) for the Treatment of Pediatric High-Risk Neuroblastoma

PR Newswire March 10, 2015

United Therapeutics Corporation To Present At The Cowen And Company 35th Annual Healthcare Conference

PR Newswire February 25, 2015

United Therapeutics Corporation Reports 2014 Fourth Quarter And Annual Financial Results

PR Newswire February 24, 2015

United Therapeutics Corporation To Announce Fourth Quarter And Annual 2014 Financial Results Before Market Open On Tuesday, February 24, 2015

PR Newswire February 17, 2015